LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step von Mar, Katrina B., Rinkenberger, Nicholas R., Boys, Ian N., Eitson, Jennifer L., McDougal, Matthew B., Richardson, R. Blake, Schoggins, John W.

Volltext

LY6E impairs coronavirus fusion and confers immune control of viral disease von Pfaender, Stephanie, Mar, Katrina B., Michailidis, Eleftherios, Kratzel, Annika, Boys, Ian N., V’kovski, Philip, Fan, Wenchun, Kelly, Jenna N., Hirt, Dagny, Ebert, Nadine, Stalder, Hanspeter, Kleine-Weber, Hannah, Hoffmann, Markus, Hoffmann, Hans-Heinrich, Saeed, Mohsan, Dijkman, Ronald, Steinmann, Eike, Wight-Carter, Mary, McDougal, Matthew B., Hanners, Natasha W., Pöhlmann, Stefan, Gallagher, Tom, Todt, Daniel, Zimmer, Gert, Rice, Charles M., Schoggins, John W., Thiel, Volker

Volltext

Functional-genomic analysis reveals intraspecies diversification of antiviral receptor transporter proteins in Xenopus laevis von Boys, Ian N., Mar, Katrina B., Schoggins, John W.

Volltext

Structural homology screens reveal host-derived poxvirus protein families impacting inflammasome activity von Boys, Ian N., Johnson, Alex G., Quinlan, Meghan R., Kranzusch, Philip J., Elde, Nels C.

Volltext

Evolution of STAT2 resistance to flavivirus NS5 occurred multiple times despite genetic constraints von Veit, Ethan C., Salim, Madihah S., Jung, Mariel J., Richardson, R. Blake, Boys, Ian N., Quinlan, Meghan, Barrall, Erika A., Bednarski, Eva, Hamilton, Rachael E., Kikawa, Caroline, Elde, Nels C., García-Sastre, Adolfo, Evans, Matthew J.

Volltext

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo von Kober, Daniel L, Caballero Van Dyke, Marley C, Eitson, Jennifer L, Boys, Ian N, McDougal, Matthew B, Rosenbaum, Daniel M, Schoggins, John W

Volltext

FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms von Ahmed, Mahmoud S., Farag, Ayman B., Boys, Ian N., Wang, Ping, Menendez-Montes, Ivan, Nguyen, Ngoc Uyen Nhi, Eitson, Jennifer L., Ohlson, Maikke B., Fan, Wenchun, McDougal, Matthew B., Mar, Katrina, Thet, Suwannee, Ortiz, Francisco, Kim, Soo Young, Solmonson, Ashley, Williams, Noelle S., Lemoff, Andrew, DeBerardinis, Ralph J., Schoggins, John W., Sadek, Hesham A.

Volltext

When viruses do not go gentle into that good night von Boys, Ian N., Elde, Nels C.

Volltext

RTP4 Is a Potent IFN-Inducible Anti-flavivirus Effector Engaged in a Host-Virus Arms Race in Bats and Other Mammals von Boys, Ian N., Xu, Elaine, Mar, Katrina B., De La Cruz-Rivera, Pamela C., Eitson, Jennifer L., Moon, Benjamin, Schoggins, John W.

Volltext

Evolution of the interferon response: lessons from ISGs of diverse mammals von McDougal, Matthew B, Boys, Ian N, De La Cruz-Rivera, Pamela, Schoggins, John W

Volltext

Shiftless inhibits flavivirus replication in vitro and is neuroprotective in a mouse model of Zika virus pathogenesis von Hanners, Natasha W., Mar, Katrina B., Boys, Ian N., Eitson, Jennifer L., Cruz-Rivera, Pamela C. De La, Richardson, R. Blake, Fan, Wenchun, Wight-Carter, Mary, Schoggins, John W.

Volltext

A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication von Richardson, R. Blake, Ohlson, Maikke B., Eitson, Jennifer L., Kumar, Ashwani, McDougal, Matthew B., Boys, Ian N., Mar, Katrina B., De La Cruz-Rivera, Pamela C., Douglas, Connor, Konopka, Genevieve, Xing, Chao, Schoggins, John W.

Volltext

LY6E impairs coronavirus fusion and confers immune control of viral disease von Pfaender, Stephanie, Mar, Katrina B., Michailidis, Eleftherios, Kratzel, Annika, Boys, Ian N., V'kovski, Philip, Fan, Wenchun, Kelly, Jenna N., Hirt, Dagny, Ebert, Nadine, Stalder, Hanspeter, Kleine-Weber, Hannah, Hoffmann, Markus, Hoffmann, H. Heinrich, Saeed, Mohsan, Dijkman, Ronald, Steinmann, Eike, Wight-Carter, Mary, McDougal, Matthew B., Hanners, Natasha W., Poehlmann, Stefan, Gallagher, Tom, Todt, Daniel, Zimmer, Gert, Rice, Charles M., Schoggins, John W., Thiel, Volker

Volltext

Identification of FDA Approved Drugs with Antiviral Activity against SARS-CoV-2: A Tale from structure-based drug repurposing to host-cell mechanistic investigation von Ahmed, Mahmoud S., Farag, Ayman B., Boys, Ian N., Wang, Ping, Menendez-Montes, Ivan, Nguyen, Ngoc Uyen Nhi, Eitson, Jennifer L., Ohlson, Maikke B., Fan, Wenchun, McDougal, Matthew B., Mar, Katrina, Thet, Suwannee, Ortiz, Francisco, Kim, Soo Young, Solmonson, Ashley, Williams, Noelle S., Lemoff, Andrew, DeBerardinis, Ralph J., Schoggins, John W., Sadek, Hesham A.

Volltext

DE3012734 von KIBBLEWHITE, IAN E., DUBLIN, IE, BOYS, JOHN T., , BIRKENHEAD, NZ, TAMBINI, ANGELO L., MANOR KILBRIDE, WICKLOW, IE

Volltext bestellen